Christine Jacob

Christine Jacob has a diverse and extensive work experience spanning over several industries. Christine is currently working as a Project Management Consultant at the Bill & Melinda Gates Medical Research Institute since November 2021. Prior to this, they served as the Director of Medical Affairs, Program Management and Operations at Regeneron Pharmaceuticals, Inc. from September 2018 to November 2021.

Before their role at Regeneron, Jacob held positions in various pharmaceutical companies. Christine worked as an Associate Director of Program Management at Otsuka Pharmaceutical Companies (U.S.) from January 2016 to August 2018. Prior to that, they served as the Director of Program Management at Merz North America, where they oversaw multiple programs and therapeutic areas with a high degree of complexity. Christine'sresponsibilities included strategic planning and optimization of global development processes. Christine also held the position of Director of Program Management and Clinical Operations at Merz North America, where they managed budgets, forecasted for specified therapeutic areas, and played an active role in international task forces.

Earlier in their career, Jacob worked as the Clinical Director at Aegera Therapeutics Inc., where they led multidisciplinary study teams and managed various oncology studies. Christine also gained experience in project management and clinical roles at Ambrilia Biopharma Inc., gereq, and Quintiles.

Jacob completed their MBA at the Université de Sherbrooke in 2008 and started their career as a Clinical Research Associate at sanofi-aventis in 1991. Overall, they bring a wealth of experience in project management, clinical operations, and strategic planning to their current role as a Project Management Consultant.

Christine Jacob has a Master of Science degree in pathology from McGill University in Montreal, QC, Canada. Christine also holds a Master of Science degree, an MBA degree, and a PMP certification from McGill University, with a focus on Cytogenetics, Genetics, and Clinical Genetics Technology. Additionally, they obtained a Master of Business Administration degree from Université de Sherbrooke.